Market Cap

Edesa Biotech, Inc. Market Capitalization:

$12.5 Million

USD as of Jan. 1, 2026

business Edesa Biotech, Inc. Company Profile

Edesa Biotech, Inc. Main Stock Listing

NASDAQ: EDSA

Market Capitalization History of Edesa Biotech, Inc.

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $158.96 B
Vertex Pharmaceuticals Incorporated $115.92 B
CSL Limited $95.75 B
Regeneron Pharmaceuticals, Inc. $82.28 B
Marinomed Biotech AG $70.11 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $968.50 B
Johnson & Johnson $499.57 B
AbbVie $405.28 B
Roche $332.12 B
UnitedHealth Group $304.72 B

Yearly evolution of Edesa Biotech, Inc. market cap

Date Market Cap YoY Change
Jan. 1, 2026 $12.5 M 101.39%
Jan. 1, 2025 $6.2 M -55.92%
Jan. 1, 2024 $14.1 M -48.55%
Jan. 1, 2023 $27.4 M -64.25%
Jan. 1, 2022 $76.6 M -28.12%
Jan. 1, 2021 $106.5 M 82.86%
Jan. 1, 2020 $58.3 M -60.23%
Jan. 1, 2019 $146.5 M -77.55%
Jan. 1, 2018 $652.5 M -56.02%
Jan. 1, 2017 $1.48 B -70.16%
Jan. 1, 2016 $4.97 B -40.74%
Jan. 1, 2015 $8.39 B -28.95%
Jan. 1, 2014 $11.81 B 300.00%
Jan. 1, 2013 $2.95 B -17.39%
Jan. 1, 2012 $3.57 B -56.60%
Jan. 1, 2011 $8.23 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

Edesa Biotech, Inc. Categories

Canada languages Healthcare languages Biotechnology
Canada Healthcare Canada Biotechnology

Stocks & Indices

Edesa Biotech, Inc. has the following listings and related stock indices.


Stock: NASDAQ: EDSA

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.